According to Ben Cade, the Chief Executive Officer of Trustonic, “Investment in connected healthtech is increasing and IVD is an important segment in the global diagnostics industry. These solutions add significant value to diagnosis and treatment, enhancing the well-being of the general public while increasing productivity and reducing costs. But, where personal data this sensitive is being captured, processed, and transmitted, the appropriate steps must be taken to protect it from malicious actors.”
The above statement was released in line with their new announcement that Trustonic Secured Platform (TSP) was selected by Optolane as a means of ensuring security and trust to the company’s new connected medical diagnostic device.
The product is primarily used at the point-of-care for early diagnosis and preventative healthcare, particularly for diagnosing cancer, infectious Trustonic’s hardware-backed security platform, TSP, enables secure and private data extraction, processing, storage and transmission.
- Enables a secure image processing channel from the sensor to the application processor;
- Provides cryptographic tools to protect individuals’ sensitive medical data;
- Ensures data integrity;
- Creates a secure environment to run algorithms analyzing raw data from the sensor;
- Encrypts sensitive data when being shared with the cloud.
- and congenital abnormalities.
Do Young Lee, CEO of OPTOLANE, says: “There is clear demand for innovative new diagnostics solutions that go from ‘sample-to-answer’ in real-time. Importantly, though, we fully understand our responsibility to protect patient data. To deliver connectivity while protecting the sensitive personal data collected by diagnostic devices, we needed a proven hardware-backed security foundation. Trustonic’s experience protecting smartphones, wearables and IoT hardware and securing critical mobile applications in the financial and automotive sectors is assurance that our devices and patient data are secured to the highest standard.”